Scribd Logo
Upload

Welcome to Scribd!

  • 21 views

    Sun Pharma

    Uploaded by

    shashank kumar

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd

    Sun Pharma

    Uploaded by

    shashank kumar
    21 views14 pages

    Original Title

    sun pharma

    Copyright

    © © All Rights Reserved

    Available Formats

    PPTX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    21 views14 pages

    Sun Pharma

    Uploaded by

    shashank kumar

    Copyright:

    © All Rights Reserved
    Download as PPTX, PDF, TXT or read online from Scribd
    Download as pptx, pdf, or txt
    You are on page 1of 14

    Sun

    Pharmaceuticals

    Presented by: Shashank Kumar


    About Sun Pharma

    Sun Pharmaceuticals is the largest pharmaceutical company from India and the 4th
    largest generic company in the world. It has capabilities across dosage forms like
    injectables, sprays, ointments, creams, liquids, tablets, and capsules. Its businesses
    include producing generics, branded generics, over the counter (OTC) products,
    active pharmaceutical ingredients (APIs) and intermediates in the full range of
    dosage forms. It also produces specialty APIs. In FY19, US formulations
    contributed the most to company’s sales with 37%, followed by India branded
    formulations at 26%.
    Dilip Shanghvi

    He is the founder and managing director of Sun Pharmaceuticals. Born in a small


    town as the son of a wholesale drug distributor, Shanghvi graduated from the
    University of Calcutta with a bachelor’s degree in commerce. As a young man he
    worked along with his father helping him in his wholesale generic drugs business
    when the idea of opening his own drug manufacturing unit struck him. Despite his
    lack of a formal science education, he started Sun Pharmaceutical Industries with a
    two-man marketing team and five products in 1982.
    The journey
    • 1983 – first manufacturing plant at Vapi, Gujrat with 5 products and two-person
    marketing team. 
    • 1990 - added two more products and established a research centre.
    • 1994 – launched their first IPO.
    • 1996 - Sales network expanded across 24 countries.
    • 1997 - first international acquisition – Caraco Pharmaceutical Laboratories,
    USA.
    • 2007 -established Sun Pharma Advanced Research Company.
    • 2014 - Became world’s fifth largest specialty generic pharmaceutical company
    with acquisition of Ranbaxy.
    • 2015 - acquired GSK’s Opiates business in Australia.
    • 2016 - acquired Biosintez to enter in Russian market.
    • 2018 - acquired Pola Pharma in Japan.
    • 2019 - entered Greater China market through partnership with China Medical
    System Holdings.
    • 2021 - Drugs Controller General of India (DCGI) has granted Sun Pharma an
    Emergency Use Authorization (EUA) to manufacture and distribute Molxvir.
    • 2022 - entered into the nutrition bar segment in India with the launch of Revital
    NXT.
    Awards and recognitions
    • Golden Peacock Award for Corporate Social Responsibility, 2020
    • listed among the Forbes World’s Best Employers 2020.
    • listed among the Forbes World’s Best Regarded companies 2019.
    • listed among the Forbes World’s Most Innovative companies 2018.
    • listed among the Forbes World’s Best Employers 2018.
    • received Best CSR Practices Award from The Economic Times 2017.
    • listed among the Forbes World 100 Most Innovative Companies
    2014 and  Forbes Asia’s Fab 50 Companies 2013.
    • received NDTV Profit’s Business Leadership Award in 2008.
    Vision -
    Reaching People And Touching Lives Globally As A
    Leading Provider Of Valued Medicines
    Mission -
    Quality, Reliability, Trust, Consistency, Innovation

    You might also like

    pFad - Phonifier reborn

    Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

    Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


    Alternative Proxies:

    Alternative Proxy

    pFad Proxy

    pFad v3 Proxy

    pFad v4 Proxy